Sexually transmitted diseases and incarceration

Current Opinion in Infectious Diseases

Volumn 22, Issue 1, 2009, Pages 77-81

  Hammett, Theodore M ^a  

^a ABT ASSOCIATES   (United States)

Author keywords

Jails; Juvenile detention facilities; Prisons; Sexually transmitted diseases

Indexed keywords

ANTIBIOTIC AGENT; VACCINE;

BEHAVIOR CHANGE; CHLAMYDIASIS; CONDOM; DISEASE TRANSMISSION; GONORRHEA; HEALTH CARE COST; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JUVENILE; PREVALENCE; PRISON; PRISONER; PUBLIC HEALTH; REVIEW; RISK REDUCTION; SCREENING TEST; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UNITED STATES;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; FEMALE; GONORRHEA; HUMANS; MALE; PREVALENCE; PRISONS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SYPHILIS; UNITED STATES; YOUNG ADULT;

EID: 58849138854     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328320a85d     Document Type: Review

References (26)

1. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002; 92:189-194.
2. Glaser JB, Greifinger RB. Correctional healthcare: a public health opportunity. Ann Int Med 1993; 118:139-145.
3. Kahn RH, Joesoef R, Aynalem G, et al. Overview of sexually transmitted diseases. In: Puisis M, editor. Clinical practice in correctional medicine, 2nd ed. Philadelphia: Mosby Elsevier; 2006. pp. 175-181.
4. Rietmeijer CA, Hopkins E, Geisler WM, et al. Chlamydia trachomatis positivity rates among men tested in selected venues in the United States: a review of the recent literature. Sex Transm Dis 2008; 35. [Epub ahead of print]
5. McDonnell DD, Levy V, Morton TJM. Risk factors for chlamydia among young women in a northern California juvenile detention facility: implications for community intervention. Sex Transm Dis 2008; 35. [Epub ahead of print]
6. Satterwhite CL, Joesoef MR, Datta SD, et al. Chlamydia trachomatis infections among men in the United States. Sex Transm Dis 2008; 35. [Epub ahead of print]
7. Pathela P, Hennessy RR, Blank S, et al. The contribution of a urine-based jail screening program to citywide male chlamydia and gonorrhea case rates in New York City. Sex Transm Dis 2007; 34. [Epub ahead of print] This study clearly demonstrates the substantial burden of STDs among jail inmates and the potential contribution of expanded STD screening in jails to an overall STD control program in a large city.
8. Kahn RH, Voigt RF, Swint E, Weinstock H. Early syphilis in the United States identified in corrections facilities, 1999-2002. Sex Transm Dis 2004; 31:360-364.
9. Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health 2006; 96:974-978.
10. Wolfe Ml, Xu F, Patel P, et al. An outbreak of syphilis in Alabama prisons: correctional health policy and communicable disease control. Am J Public Health 2001; 91:1220-1225.
11. Van Hoeven KH, Rooney WC, Joseph SC. Evidence of gonococcal transmission within a correctional system. Am J Public Health 1990; 80:1505 -1506.
12. National Commission on Correctional Healthcare. Standards for health services in prisons. Chicago: National Commission on Correctional Healthcare; 2003.
13. National Commission on Correctional Healthcare. Standards for health services in jails. Chicago: National Commission on Correctional Healthcare; 2003.
14. National Commission on Correctional Healthcare. Standards for health services in juvenile detention and confinement facilities. Chicago: National Commission on Correctional Healthcare; 2004.
15. Miller JL, Samoff E, Bolan G, for the Chlamydia Screening Project (CLASP) Group. Implementing chlamydia screening programs in juvenile settings: the California experience. Sex Transm Dis 2008; 35. [Epub ahead of print]
16. Kraut-Becher JR, Gift TL, Haddix AC, et al. Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails. J Urban Health 2004; 81:453-471.
17. Gift TL, Blake DR, Gaydos CA. The cost-effectiveness of screening men for Chlamydia trachomatis. Sex Transm Dis 2008; 35. [Epub ahead of print]
18. Gift TL, Lincoln T, Tuthill R, et al. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community. Sex Transm Dis 2006; 33 (Suppl):S103-S110.
19. Barry PM, Kent CK, Scott KC. Optimising sexually transmitted infection screening in correctional facilities: San Francisco, 2003-2005. Sex Transm Infect 2007; 83:416-418. This study employs comparative data on STD screening from jails and juvenile facilities to propose a priority list of incarcerated populations for STD screening. This is particularly important when limited resources preclude universal screening.
20. Templeton DJ. Sexually transmitted infection and blood-borne virus screening in juvenile correctional facilities: a review of the literature and recommendations for Australian centres. J Clin Forensic Med 2006; 13:30-36.
21. Hammett TM, Kennedy S, Kuck S. National survey of infectious diseases in correctional facilities: HIV and sexually transmitted diseases. Report submitted to CDC and NIJ, 19 January 2007. Available at http://www.ncjrs.gov/pdffiles1 /nij/grants/217736.pdf.
22. Wolitski PJ. Relative efficacy of a multisession sexual risk reduction intervention for young men released from prisons in 4 states. Am J Public Health 2006; 96:1854-1861.
23. Myers J, Zack B, Kramer K, et al. Get connected: an HIV prevention case management program for men and women leaving California prisons. Am J Public Health 2005; 95:1682-1 684.
24. Spaulding AC, Arriola KJA, Ramos KL, et al. Enhancing linkages to HIV primary care in jail settings: report on a consultants' meeting. J Corr Healthcare 2007; 13:93-128.
25. Tucker JD, Chang SW, Tulsky JP. The catch 22 of condoms in US correctional facilities. BMC Public Health 2007; 7:296-298.
26. Tedeschi SK, Bonney LB, Manalo R, et al. Vaccination in juvenile correctional facilities: state practices, hepatitis B, and the impact on anticipated sexually transmitted infection vaccines. Public Health Rep 2007; 122:44-48.